These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 18519086

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effect of the cGMP pathway on AQP2 expression and translocation: potential implications for nephrogenic diabetes insipidus.
    Boone M, Kortenoeven M, Robben JH, Deen PM.
    Nephrol Dial Transplant; 2010 Jan; 25(1):48-54. PubMed ID: 19666909
    [Abstract] [Full Text] [Related]

  • 23. Routing of the aquaporin-2 water channel in health and disease.
    Deen PM, van Balkom BW, Kamsteeg EJ.
    Eur J Cell Biol; 2000 Aug; 79(8):523-30. PubMed ID: 11001488
    [Abstract] [Full Text] [Related]

  • 24. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).
    Bichet DG, Bockenhauer D.
    Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):263-76. PubMed ID: 27156763
    [Abstract] [Full Text] [Related]

  • 25. Vasopressin type-2 receptor and aquaporin-2 water channel mutants in nephrogenic diabetes insipidus.
    Deen PM, Knoers NV.
    Am J Med Sci; 1998 Nov; 316(5):300-9. PubMed ID: 9822112
    [Abstract] [Full Text] [Related]

  • 26. Potential of nonpeptide (ant)agonists to rescue vasopressin V2 receptor mutants for the treatment of X-linked nephrogenic diabetes insipidus.
    Los EL, Deen PM, Robben JH.
    J Neuroendocrinol; 2010 May; 22(5):393-9. PubMed ID: 20163515
    [Abstract] [Full Text] [Related]

  • 27. Molecular and cellular defects in nephrogenic diabetes insipidus.
    Knoers NV, Deen PM.
    Pediatr Nephrol; 2001 Dec; 16(12):1146-52. PubMed ID: 11793119
    [Abstract] [Full Text] [Related]

  • 28. Vasopressin increases S261 phosphorylation in AQP2-P262L, a mutant in recessive nephrogenic diabetes insipidus.
    Trimpert C, van den Berg DT, Fenton RA, Klussmann E, Deen PM.
    Nephrol Dial Transplant; 2012 Dec; 27(12):4389-97. PubMed ID: 22778181
    [Abstract] [Full Text] [Related]

  • 29. Novel mutation of aquaporin-2 gene in a patient with congenital nephrogenic diabetes insipidus.
    Moon SS, Kim HJ, Choi YK, Seo HA, Jeon JH, Lee JE, Lee JY, Kwon TH, Kim JG, Kim BW, Lee IK.
    Endocr J; 2009 Dec; 56(7):905-10. PubMed ID: 19461158
    [Abstract] [Full Text] [Related]

  • 30. Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity.
    Li Y, Shaw S, Kamsteeg EJ, Vandewalle A, Deen PM.
    J Am Soc Nephrol; 2006 Apr; 17(4):1063-72. PubMed ID: 16495377
    [Abstract] [Full Text] [Related]

  • 31. Methyl-beta-cyclodextrin induces vasopressin-independent apical accumulation of aquaporin-2 in the isolated, perfused rat kidney.
    Russo LM, McKee M, Brown D.
    Am J Physiol Renal Physiol; 2006 Jul; 291(1):F246-53. PubMed ID: 16449354
    [Abstract] [Full Text] [Related]

  • 32. Genetic deletion of the nuclear factor of activated T cells 5 in collecting duct principal cells causes nephrogenic diabetes insipidus.
    Petrillo F, Chernyakov D, Esteva-Font C, Poulsen SB, Edemir B, Fenton RA.
    FASEB J; 2022 Nov; 36(11):e22583. PubMed ID: 36197017
    [Abstract] [Full Text] [Related]

  • 33. AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions.
    Gao C, Higgins PJ, Zhang W.
    Cells; 2020 Sep 26; 9(10):. PubMed ID: 32993088
    [Abstract] [Full Text] [Related]

  • 34. [Nephrogenic diabetes insipidus].
    Evrard A, Lefebvre J, Vantyghem M.
    Ann Endocrinol (Paris); 1999 Dec 26; 60(6):457-64. PubMed ID: 10617799
    [Abstract] [Full Text] [Related]

  • 35. Physiopathology and diagnosis of nephrogenic diabetes insipidus.
    Devuyst O.
    Ann Endocrinol (Paris); 2012 Apr 26; 73(2):128-9. PubMed ID: 22503803
    [Abstract] [Full Text] [Related]

  • 36. Congenital nephrogenic diabetes insipidus: the current state of affairs.
    Wesche D, Deen PM, Knoers NV.
    Pediatr Nephrol; 2012 Dec 26; 27(12):2183-204. PubMed ID: 22427315
    [Abstract] [Full Text] [Related]

  • 37. An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex.
    Mulders SM, Bichet DG, Rijss JP, Kamsteeg EJ, Arthus MF, Lonergan M, Fujiwara M, Morgan K, Leijendekker R, van der Sluijs P, van Os CH, Deen PM.
    J Clin Invest; 1998 Jul 01; 102(1):57-66. PubMed ID: 9649557
    [Abstract] [Full Text] [Related]

  • 38. [Water metabolism and its disturbances].
    Shoji M, Yasujima M.
    Rinsho Byori; 1999 Dec 01; 47(12):1121-7. PubMed ID: 10639821
    [Abstract] [Full Text] [Related]

  • 39. Fluconazole Increases Osmotic Water Transport in Renal Collecting Duct through Effects on Aquaporin-2 Trafficking.
    Vukićević T, Hinze C, Baltzer S, Himmerkus N, Quintanova C, Zühlke K, Compton F, Ahlborn R, Dema A, Eichhorst J, Wiesner B, Bleich M, Schmidt-Ott KM, Klussmann E.
    J Am Soc Nephrol; 2019 May 01; 30(5):795-810. PubMed ID: 30988011
    [Abstract] [Full Text] [Related]

  • 40. [Nephrogenic diabetes insipidus].
    Ishikawa S.
    Nihon Rinsho; 1996 Mar 01; 54(3):819-24. PubMed ID: 8904243
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.